Evidence map›Paper›PMID 42827133›Full record

ArticleNature communications2026

Tonicity drives collecting duct maturation in the mammalian kidney.

Daisuke Inoue, Koichiro Miike, Shunsuke Tanigawa, Kei-Ichiro Yasunaga, Rae Maeda, Tomoko Ohmori, Sayoko Fujimura, Masashi Mukoyama, Tomomi Kamba, Jose Aramburu and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daisuke InoueDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Koichiro MiikeDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Shunsuke TanigawaDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-0642-6446
Kei-Ichiro YasunagaLiaison Laboratory Research Promotion Center, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Rae MaedaCenter for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tomoko OhmoriDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Sayoko FujimuraLiaison Laboratory Research Promotion Center, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Masashi MukoyamaDepartment of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
Tomomi KambaDepartment of Urology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
Jose AramburuImmunology Unit, Department of Medicine and Life Sciences, Universitat Pompeu Fabra and Barcelona Biomedical Research Park, Barcelona, Spain.ORCID 0000-0001-9279-9523
Cristina Lopez-RodriguezImmunology Unit, Department of Medicine and Life Sciences, Universitat Pompeu Fabra and Barcelona Biomedical Research Park, Barcelona, Spain.ORCID 0000-0002-2311-2406
Yuki SugiuraCenter for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0002-6983-8958
Yuichiro IzumiDepartment of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
Ryuichi NishinakamuraDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan. ryuichi@kumamoto-u.ac.jp.ORCID 0000-0003-4064-2860

Funding

Japan Agency for Medical Research and Development (AMED) JP26bm1423043MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05050MEXT | Japan Society for the Promotion of Science (JSPS) JP24K23941Ministry of Education, Culture, Sports, Science and Technology (MEXT) JPMXP1323015486Ministry of Education, Culture, Sports, Science and Technology (MEXT) not applicable
6 · The paper itself

Abstract

Organ maturation is a fundamental biological process and a major challenge for organoid-based regenerative medicine. During kidney maturation, osmolality increases in the renal medulla for urine concentration, yet whether this extreme environment conversely contributes to kidney maturation remains unclear. Here we show that high tonicity, i.e., salt, drives morphological, transcriptional, and functional maturation of medullary collecting ducts (CDs) primarily via nuclear factor of activated T cells 5 (NFAT5). This occurs both in vitro and in vivo. Combining high tonicity with maturation-promoting hormones, we establish a robust maturation protocol for human medullary CD organoids and a functional assay to measure water permeability in CD organoids, enabling modeling of three disease states: NFAT5 deletion, and lithium-induced and congenital nephrogenic diabetes insipidus. Collectively, high tonicity drives mammalian kidney maturation, offering a promising platform to maximize the potential of organoids for future therapies.

Indexed as

Kidney Tubules, CollectingAnimalsDiabetes Insipidus, NephrogenicHumansKidneyKidney MedullaMiceMice, KnockoutOrganoidsOsmolar Concentration

Identifiers

PMID42827133
PMCPMC13633243

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.